FIELD: medicine.
SUBSTANCE: group of inventions relates to methods for determining whether individual suffering cancer disease, positive at mutations ALK, respond to ALK inhibitor treatment, and/or whether there is probability that patient suffering cancer disease, such disease is progressing slower, as well as to kit.
EFFECT: group of inventions enables assessing efficacy of treating cancer based on identification of new mutations in anaplastic lymphoma kinase.
30 cl, 5 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GENE (LBFL313) FAMILY ASSOCIATED WITH MALIGNANT GROWTH OF PANCREAS | 2007 |
|
RU2432399C2 |
| MTS GENE, MUTATIONS OF THIS GENE AND METHODS OF DIAGNOSIS OF MALIGNANT TUMORS USING MTS GENE SEQUENCE | 1995 |
|
RU2164419C2 |
| MUTATIONS OF MTS GENE IN EMBRYONIC LINE AND METHOD OF DETECTION OF PREDISPOSITION TO MALIGNANT TUMORS | 1995 |
|
RU2161309C2 |
| NUCLEOTIDE SEQUENCES ASSOCIATED WITH INCREASING OR REDUCING OF OVULATORY RATE IN MAMMALIANS | 2001 |
|
RU2283866C2 |
| COMPOSITIONS, AGENTS, KITS AND TECHNIQUES FOR DIAGNOSING, MONITORING AND TREATING OBESITY AND/OR DIABETES | 2004 |
|
RU2420583C2 |
| AVIAN TELOMERASE REVERSE TRANSCRIPTASE | 2007 |
|
RU2415867C2 |
| PHAGE φ-mru POLYNUCLEOTIDES AND POLYPEPTIDES AND THEIR APPLICATION | 2008 |
|
RU2520738C2 |
| NOVEL FLUORESCENT PROTEINS FROM ENTACMAEA QUADRICOLOR AND METHOD OF OBTAINING SAID PROTEINS | 2007 |
|
RU2395581C2 |
| IMPROVED EXPRESSION VECTORS OF MAMMALS AND THEIR USE | 2009 |
|
RU2502800C2 |
| BRAF MUTATIONS ENSUING RESISTANCE TO BRAF INHIBITORS | 2011 |
|
RU2571930C2 |
